W.M.). The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/Objective-Apoptosis signal-regulating kinase 1-interacting protein-1 (AIP1) is a signaling adaptor molecule implicated in stress and apoptotic signaling induced by proinflammatory mediators. However, its function in atherosclerosis has not been established. In the present study, we use AIP1-null (AIP1 −/− ) mice to examine its effect on atherosclerotic lesions in an apolipoprotein E-null (ApoE −/− ) mouse model of atherosclerosis.
M yocardial infarction caused by atherosclerosis of coronary arteries remains the leading cause of death in the United States. Atherosclerosis involves plaque formation in the arterial wall and is characterized by inflammation, lipid accumulation, smooth muscle cell proliferation/neointima expansion, cell death, and fibrosis. 1, 2 Subendothelial retention and accumulation of lipoproteins could be converted to atherogenic remnant lipoproteins and low-density lipoprotein (LDL). 3, 4 A key early inflammatory response to retained lipoproteins is activation of vascular endothelial cells (EC), which may be enhanced by oxidative modifications of these lipoproteins. Activated EC increase expressions of adhesion molecules and chemokines which in turn promote infiltration of immune cells, including macrophages, neutrophils, master cells, dendritic cells, and T cells. 2, 5 Macrophages take up native and oxidized LDL to become lipid-laden foam cells and together with other cells release atherogenic cytokines and other activators, such as reactive oxygen species, which exacerbate EC dysfunction (characterized by a reduction in amount of bioavailable nitric oxide) and EC apoptosis, and promote atherosclerotic plaque development. 6 Therefore, the phenotypic changes in EC may be an early event during initiation and progression of atherosclerosis. 2, 7, 8 Defining genes and pathways critical in EC function may provide therapeutic targets for treatment of atherosclerosis.
We have identified apoptosis signal-regulating kinase 1-interacting protein-1 (AIP1), a protein highly expressed in vascular endothelium, as a novel signaling scaffolding protein that mediates EC changes induced by inflammatory stimuli. [9] [10] [11] [12] [13] [14] AIP1 was initially identified as an apoptosis signal-regulating kinase 1-interacting protein as a positive regulator in tumor necrosis factor-α (TNF)-induced c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase signaling. 9 It contains multiple functional domains, including pleckstrin homology, protein kinase C-conserved region 2, Ras-GTP-activating protein (therefore is a new member of the Ras-GTP-activating protein family) at the N-terminal half while a period-like domain, a proline-rich region, a coiled-coil and leucine-zipper as well as a phospho-serine for 14-3-3 and Akt binding at its C-terminal half. 15 Thereafter we have shown that AIP1 can act as an inhibitor of TNF-induced nuclear factor-κB (NF-κB) activation by inhibiting receptor-interacting protein-1 and IκBα kinase kinase activity. 10, 11 It has been proposed that AIP1 differentially regulates tumor necrosis factor-α receptor 1 signaling complexes. Specifically, AIP1 inhibits membrane-bound and IκBα kinase-activating tumor necrosis factor-α receptor-1 complex I, whereas promoting the JNK-activating complex (we named the AIP1 complex). 10 Interestingly, we have shown that AIP1 suppresses toll-like receptor (TLR) 4-mediated activation of both the JNK and NF-κB signaling pathways in EC. 13 We further show that AIP1 functions as a novel Arf6-GTP-activating protein to negatively regulate phosphatidylinositol 4, 5-bisphosphate-dependent assembly of the TLR4-TIRAP-MyD88 signaling complex. Recently, we have shown that AIP1 in vascular smooth muscle cells inhibits interferon (INF)-γ-induced Janus kinase-2 signaling pathways. 14 Therefore, AIP1 appears to function as a general suppressor of inflammatory signaling.
In supporting our in vitro studies, analyses from AIP1-null mice (AIP1 −/− ) demonstrate AIP1 functions as an inflammatory suppressor. AIP1 −/− mice are viable without obvious defects in vascular development. However, AIP1 −/− mice show dramatically enhanced inflammatory responses in ischemic hindlimb, inflammatory sponge, and graft arteriosclerosis models. 12, 14 Interestingly, a recent human genome-wide association study (GWAS) has identified a sequence variant within intron 1 of the AIP1 (DAB2IP) gene (rs7025486) conferring susceptibility to coronary artery disease, including abdominal aortic aneurysm, peripheral vascular disease, early onset of myocardial infarction, and pulmonary embolism. 16 How AIP1 is involved in coronary artery disease, such as in atherosclerosis is still unknown. In the present study, we determine the effects of AIP1 global deletion on atherosclerotic progression in an apolipoprotein E (ApoE)null mouse model. The ApoE-null or the LDL receptor-null mice, which have impaired LDL clearance, are the most commonly used mouse models of atherosclerosis. Moreover, hyperlipidemia exacerbates inflammation and EC dysfunction in the ApoEnull mice, which are important early events for the development of atherosclerosis. [17] [18] [19] Our current data suggest that AIP1 suppresses atherosclerosis progression by limiting hyperlipidemiainduced inflammation and vascular endothelial dysfunction.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

A Global Deletion of AIP1 Facilitates Hyperlipidemia-Induced Atherosclerosis in ApoE −/− Mouse Model
To study the functional role of AIP1 in atherogenesis, we subjected the ApoE −/− AIP1 −/− double knockout (DKO) and corresponding ApoE −/− mice to a Western-type diet containing 1.25% cholesterol for 10 weeks. Lipid-rich and atherosclerotic plaques were visualized by opening the aortas longitudinally followed by oil red-O staining. AIP1 deletion significantly increased the number and size of aortic plaques at 10 weeks in the ApoE −/− mice ( Figure 1A ). Lesion areas were greater throughout the aortic arch, thoracic aorta, and abdominal region ( Figure 1A and 1B). We also quantified lesion areas in cross-sections of the aortic roots. AIP1 deletion increased the lesion area in the aortic roots compared with that observed in ApoE −/− mice ( Figure 1C with quantification in Figure 1D ). Moreover, severe atherosclerosis was detected in the coronary artery of DKO (indicated by arrows in Figure 1C ). This phenotype is atypical for the ApoE −/− mice, but has been reported in the ApoE −/− mice after feeding with Western-type diet for 10 months, 20, 21 and in ApoE −/− mice that lack additional gene, such as LDL receptor, 22 scavenger receptor B1 (SR-BI) 23 or Akt1 gene, 24 or ApoE −/− bred to mice expressing urokinase in the macrophages. 25
AIP1 Deletion Increases Lesion Expansion and Macrophage Infiltration in the Aorta and Innominate Artery in Hyperlipidemic ApoE −/− Mice
In addition to aortas and coronary lesions, we also compared the lesions in the innominate (branchiocephalic) arteries. We found that AIP1 deletion significantly increased atheroma areas with reduced lumens at 10 weeks ( Figure 2A and 2B for H and E and oil-red staining with quantifications in Figure 2C and 2D). The increased plaque areas correlated with increased macrophage (CD68 + ) infiltration in branchiocephalic arteries ( Figure 2E with quantification in Figure 2F ) and aortic roots ( Figure Thus, the genetic loss of AIP1 increases aortic and coronary atherogenesis and macrophage infiltrations, and does not involve the smooth muscle cells. We also measured the circulating monocytes (which infiltrate into tissue and become macrophages) in the blood of ApoE and DKO mice by complete blood count. No differences were detected between the ApoE −/− and DKO mice in circulating monocytes ( Figure IC in the online-only Data Supplement), suggesting that a higher number of macrophages in the DKO plaque was likely attributable to enhanced monocyte infiltration into the vascular wall of DKO mice.
AIP1 Deletion Has No Effects on Body Weight, Serum Cholesterol and Triglyceride Levels, and Lipoprotein Profiles in Hyperlipidemic ApoE −/− Mice
Because lipid metabolism contributes significantly to atherosclerosis, we next examined the effects of AIP1 on multiple metabolic parameters in mice fed with chow or Western-type diet for 10 weeks. We did not detect obvious differences between the ApoE −/− and DKO in body weight, serum cholesterol, and triglyceride levels ( Figure 3A and 3C). Lipoprotein profiles of very low-density lipoprotein, intermediate-density lipoprotein/low-density lipoprotein, and high-density lipoprotein were also similar between the 2 groups ( Figure 3D and 3E). These data suggest that augmented atherosclerotic lesion formation by AIP1 deletion occurred independent of the plasma lipid profiles in the DKO mice.
AIP1 Deletion Augments Hyperlipidemia-Induced Inflammatory Cytokines With Enhanced NF-κB Signaling in Aortas of the ApoE −/− Mice
Inflammation is a key component during the initiation and progression of atherosclerosis. 2 We measured atherogenic cytokines, such as TNF, interleukin (IL)-6, and IL-12 as well as the atheroprotective cytokine IL-10. 1,26 TNF, IL-6, and IL-12, but not IL-10, were drastically increased in the ApoE −/− mice plasma after 10 weeks on a Western-type diet; this increase was further augmented in the DKO mice ( Figure 4A ). The augmented expression of proinflammatory cytokines could be attributable to increased number of macrophages in the atheroma plaque observed in the DKO aorta, or enhanced activation of transcriptional factor NF-κB and JNK-dependent c-Jun/activating transcription factor-2 that drive gene expression of TNF, IL-6, and IL-12. [27] [28] [29] [30] Therefore, we measured activities of NF-κB and JNK in the aortic lysates with phospho-p65-and p-JNK-specific antibodies. Phopho-p65 and phospho-JNK were undetectable in chow-fed aortas (not shown). However, activation of NF-κB (phopho-p65) and JNK was strongly induced in aortas from ApoE −/− mice on a Western-type diet, and was further augmented in the DKO aortas ( Figure 4B ). We further determined the cell types expressing active NF-κB in atheroma plaques by immunofluoresence staining with phopho-p65. The number of phospho-p65 positive cells was increased in DKO aortas, where the majority was detected in vascular endothelium compared with the macrophage-rich atheroma plaques ( Figure 4C with quantifications in Figure  4D ). Consistently, NF-κB-dependent EC adhesion molecule intracellular adhesion molecule-1 was also augmented by AIP1 deletion in the DKO compared with the ApoE −/− mice ( Figure  4C with quantifications in Figure 4D ). We also examined the NF-κB-dependent gene expression of macrophage recruitment chemokines monocyte chemoattractant protein-1, Rantes, and fractalkine (CX3CL1) by quantitative reverse transcription-PCR from ApoE and DKO aortas. Diet-induced gene expression of monocyte chemoattractant protein-1, Rantes, and fractalkine was also significantly augmented by AIP1 deletion ( Figure 4E ). These data suggest that augmented atherosclerotic lesion formation by AIP1 deletion was likely attributed to enhanced EC inflammatory responses in the DKO mice.
Bone Marrow Cells From ApoE −/− AIP1 −/− Donors Are Not Sufficient to Enhance Inflammatory Responses and Atherogenesis When Transferred to ApoE-KO Recipients
To confirm whether an AIP1-dependent mechanism in macrophages accounts for the increase of atherosclerosis in the DKO mice, we performed bone marrow transplantation (BMT) experiments. To verify our BMT procedure, we transplant BM cells from wild-type (WT) C57BL/6 or AIP1-KO mice (CD45.2 + ) into irradiated Pep3B recipients (CD45.1 + ) as we performed previously. 31 The engraftment ratio in BM of recipient mice was analyzed by flow cytometry analysis using CD45.2 and CD45.1 surface marker after 6 weeks of BMT. Engraftments reached >95% (percentage of CD45.2 + cells in the recipients). No difference was detected between WT and AIP1-KO BM cells in the reconstitution of recipient BM (n=4). BM cells from ApoE −/− or DKO mice were transplanted into 8-week-old, lethally irradiated ApoE −/− mice. Six weeks post-BMT, we confirmed the complete BM reconstitution by genotyping of peripheral blood cells using the AIP1 WT or KO allele-specific primers. Results show that the KO, but not WT allele-specific PCR band, was detected in DKO BMT to ApoE −/− recipients. The complete BM reconstitution was confirmed by Western blot with an AIP1-specific antibody ( Figure 5A ). We also performed complete blood tests using the peripheral blood from basal ApoE −/− , DKO, and BMT ApoE mice. Results indicated that BMs in BMT mice were completely reconstituted as measured for hemoglobin, hematocrit, numbers of red blood cell, platelet, total white blood cell as well as individual cell types, such as neutrophil, lymphocyte, and monocyte. More importantly, no significant increases in peripheral monocytes and lymphocytes were observed (compare Basal versus BMT in Table I in the online-only Data Supplement). We did not observe significant increases in tissue macrophage infiltration, 32 suggesting that BMT procedure did not promote inflammation in the recipients. The BMT mice were then fed with Western-type diet containing 1.25% cholesterol for 10 weeks. Lipid-rich and atherosclerotic plaques were visualized by opening the aortas longitudinally followed by oil red-O staining as described. Lesions throughout the aortic arch, thoracic aorta, and abdominal region as well as the cross-sections of the aortic roots were similar between the ApoE −/− mice with transplantation of DKO BM cells (BMT DKO to ApoE) and the ApoE −/− mice with transplantation of ApoE −/− BM cells (BMT ApoE to ApoE; Figure 5B and 5C for aortas; Figure 5D and 5E for aorta roots). Serum cytokines between the 2 groups were also similar ( Figure 5F ). These data demonstrate that the loss of AIP1 in BM-derived cells (macrophages) does not account for the enhanced aortic atherosclerosis in DKO mice. 
AIP1 Deletion Augments Hyperlipidemia-Induced EC Dysfunction at Early Phases of Atherosclerosis
Vascular EC is the primary cell type that limits inflammation, and EC dysfunction has been implicated as an early step for atherosclerosis development. To determine whether augmented EC dysfunction is a potential mechanism of enhanced atherosclerosis in the DKO mice, aortas from the ApoE −/− and DKO adult mice were harvested for vessel function assays after only 2 weeks on the Western-type diet when few atherosclerotic lesions could be detected. Vascular reactivity of isolated aortic rings was determined by examining the responses to the vasoconstrictor phenylepherine (PE) and the nitric oxide synthase inhibitor L-NG-nitroarginine methyl ester. 33 Aortas from DKO mice were more responsive to PE compared with the ApoE −/− mice ( Figure 6A ). Aortas from DKO mice were more responsive to PE, because a 3-fold lower concentration of PE was required to elicit constriction of the isolated aortic rings (EC 50 =4×10 −7 in DKO versus 1.2×10 −6 in ApoE −/− ). To determine whether this difference was attributable to the basal release of endothelial nitric oxide synthase-derived NO in DKO versus ApoE −/− vessels, aortic rings were preconstricted with submaximal dose of PE, and the nitric oxide synthase inhibitor L-NG-nitroarginine methyl ester (100 μmol/L) was added at the peak of the constriction to remove endogenous NO tone. On removal of the basal NO by the presence of L-NG-nitroarginine methyl ester, both vessels exhibited similar constriction response to PE (EC 50 =7.0×10 −8 for DKO versus EC 50 =7.5×10 −8 for ApoE −/− ; Figure 6B ). These effects on vasomotion occurred selectively in the endothelium, because the vasoconstrictive responses to KCl and relaxation in response to the NO donor drug sodium nitroprusside were similar between the 2 groups ( Figure 6C and 6D ). We did not observe obvious differences in chow-fed ApoE −/− and DKO mice ( Figure II in the onlineonly Data Supplement). These data suggest that Western-type diet induces EC dysfunction (reduction in basal NO activity) in the ApoE −/− mice, and this diet-induced EC dysfunction can be further augmented by AIP1 deletion at an early phase of atherosclerosis.
AIP1 Deletion Strongly Augments oxLDL-Induced Inflammatory Responses in Vascular EC
We have previously shown that AIP1 regulates cellular signaling in EC induced by proinflammatory mediators TNF, IL-1β, and TLR ligands. Specifically, TLR ligands (lipopolysaccharides for TLR4 or Pam3CSK4 for TLR2)-induced activations of the mitogen-activated protein kinase and NF-κB signaling pathways were augmented in AIP1-KO EC. 13 We determined whether AIP1 regulates signaling by oxLDL, a major proinflammatory mediator derived from LDL, using aortic EC isolated from both WT (C57BL/6) and AIP1-KO mice. oxLDL-induced activation of NF-κB and JNK in aortic EC as measured by phopho-p65 and phopho-JNK, respectively. Moreover, AIP1 deletion strongly augmented oxLDL-induced NF-κB signaling with a weaker effect on oxLDL-induced JNK activation ( Figure 7A) , consistent with the observations in the atherosclerotic aortas (Figure 4 ). In contrast, we observed only small effects of AIP1 deletion on oxLDL-induced NF-κB and JNK signaling in peritoneal macrophages ( Figure IIIA in the online-only Data Supplement). Of note, AIP1 expression in macrophages, similar to peripheral blood cells ( Figure 5A ), was very low compared with aortic EC. This was further confirmed by quantitative reverse transcription-PCR ( Figure IIIB in the online-only Data Supplement). We then examined the oxLDL-induced gene expression of macrophage-recruiting adhesion molecules (intracellular adhesion molecule-1 and vascular cell adhesion molecule-1) and chemokines (monocyte chemoattractant protein-1 and fractalkine) in ApoE −/− and DKO EC. oxLDL-induced gene expressions of adhesion molecules and chemokines were significantly augmented by AIP1 deletion ( Figure 7B ). We finally performed in vitro assays to determine the effects of AIP1 deletion on EC-leukocyte adhesion, a critical early step in inflammatory cell recruitment. 2, 34 Fluorescently prelabeled mice monocytes were seeded onto confluent primary cultured mice aortic EC that were pretreated with oxLDL. AIP1 deletion in mice EC significantly augmented oxLDLinduced monocyte attachment ( Figure 7C with quantifications in Figure 7D ). Taken together, these data suggest that AIP1 deletion in EC primarily attributed to enhanced EC activation and macrophage infiltration, leading to accelerated atherosclerosis progression in DKO mice.
Discussion
The major finding of this study is that a global deletion of AIP1 in vivo enhances hyperlipidemia-induced atherosclerotic progression in an ApoE-null mouse model of atherosclerosis. AIP1 deletion promotes a proatherogenic phenotype without significantly altering metabolic parameters, including body weight, total cholesterol levels, or lipoprotein profiles. Mechanistic studies suggest that AIP1 deletion significantly augments LDL-induced NF-κB/JNK proinflammatory signaling in vascular EC, but not in macrophages. This augmented proinflammatory signaling contributes to enhanced EC activation/dysfunction, increased macrophage accumulation in the lesion area, and exacerbated atheroma growth. In support of this conclusion, macrophages from AIP1-deficient donors do not augment inflammatory responses and atherogenesis in ApoE-KO recipients. Therefore, our current study uncovers a critical role of AIP1 in vascular EC in limiting inflammation, EC dysfunction, and atherosclerosis. Our current study further supports our general theme that AIP1 functions as a critical cellular inhibitor of inflammation in the vasculature. We have previously examined the role of AIP1 in inflammatory responses in several mouse models, including a sponge granuloma model 12 and transplant graft arteriosclerosis models. 14 In the sponge granuloma model, poly(vinyl alcohol) sponges are implanted into mice subcutaneously, and the invasion of the sponge by host cells and the formation of new tissue permit the quantification of inflammatory and angiogenic responses. AIP1 global deletion increases invasion of macrophages, foreign body responses as well as neovascularization. 12 However, these previous studies focused on how AIP1 directly regulates angiogenic receptor vascular endothelial growth factor receptor-2, whereas the mechanism for increased microphage infiltration observed in AIP1-KO mice had not been further investigated. Graft arteriosclerosis (also called allograft vasculopathy), the major cause of late cardiac allograft failure, is characterized by arterial intimal hyperplasia attributable to recruitment and proliferation of smooth muscle cells within the intima, resulting in luminal obstruction and allograft ischemia. Evidences from human studies and animal models suggest that IFN-γ, a proinflammatory cytokine produced by effector T cells, is a critical mediator for smooth muscle cell proliferation. We have shown that AIP1 deletion enhances intimal formation and graft arteriosclerosis by downregulating IFN-γ-janus kinase-2 STAT1/3-dependent migratory and proliferative signaling in smooth muscle cells. Interestingly, AIP1-mediated inhibition of IFN-γ signaling seems to be smooth muscle cell-specific as we do not observe any effects of AIP1 deletion on IFN-γ signaling in EC. 14 Therefore, our current study demonstrates a specific function of AIP1 in the vascular EC, which is primarily responsible for limiting hyperlipidemia-induced inflammatory responses and atherosclerotic lesion progression in atherosclerosis model. This conclusion is supported by the following evidences: (1) Although the ApoE −/− AIP1 −/− DKO mice exhibit increased atherosclerotic lesion with increased macrophage infiltration compared with ApoE −/− mice, smooth muscle cell contents are not significantly altered by AIP1 deletion; (2) AIP1 deletion has no effects on body weight, Figure 6 . Apoptosis signal-regulating kinase 1-interacting protein-1 (AIP1) deletion augments endothelial cell dysfunction at early phases of atherosclerosis. Apolipoprotein E-null (ApoE −/− ) and double knockout (DKO) adult mice were fed with Western-type diet for 2 weeks, and aortas were harvested for vessel function assays. A, Aortic rings were contracted with phenylepherine (PE) at a full range of doses (10 −9 -10 −4 mol/L). Constriction force (mN) is shown. B, Aortic rings were incubated with a nitric oxide synthase (NOS) inhibitor L-NG-nitroarginine methyl ester (L-NAME) (100 μmol/L) to remove basal NO synthesis and then contracted with PE as in A. C, AIP1 deletion has no effects on vessel constriction in response to KCl. Aortic rings were contracted with 50 mmol/L of KCl. D, AIP1 deletion has no effects on vessel relaxation to the NO donor drug sodium nitroprusside (SNP). Aortic rings were incubated with a NOS inhibitor L-NAME to remove basal NO synthesis followed by a precontraction with PE as in A, and were then relaxed with SNP at a full range of doses (10 −9 -10 −6 mol/L). Data have recently generated EC-specific AIP1-KO mice that will be useful in defining the function of EC-expressed AIP1 in limiting atherogenesis.
ApoE-null mouse is a widely used model for atherosclerosis. Aortas in these mice show increased oxidative stress and inflammation, and decreased endothelial function. [17] [18] [19] 33 Atherogenic stimuli, such as oxLDL, induce NF-κB signaling in EC, which drives expression of adhesion molecules on EC, mediating interactions of monocytes with EC during the initiation of atherosclerosis. Indeed, we observe that AIP1 deletion in vascular EC augments oxLDL-induced NF-κB (and JNK) signaling, gene expression of adhesion molecules, chemokines, and monocyte adhesion. Of note, AIP1 deletion has similar effects on oxLDL, and TLR2/4 signaling in EC suggests a shared function of AIP1 in these pathways. One possible explanation is that oxLDL uses TLR2/4 to activate NF-κB and JNK pathways in vascular EC. 35 OxLDL also uses unique receptor(s) to induce intracellular signaling in EC. It has been shown that lectin-like oxLDL receptor-1, a membrane protein structurally distinct from scavenger receptors on endothelial surfaces, is involved in oxLDL-induced NF-κB activation, endothelial dysfunction, and atherogenesis. [36] [37] [38] It will be interesting to investigate whether and how AIP1 plays a role in lectin-like oxLDL receptor-1-mediated signaling. In addition to NF-κB and JNK signaling, atherogenic stimuli, such as oxLDL, also induce intracellular production of reactive oxygen species in EC, which in turn may cause EC dysfunction. [39] [40] [41] We have previously shown that the ApoE −/− mice exhibit increased oxidative stress, reduced NO bioavailability, and EC dysfunction, and EC-specific expression of antioxidant protein mitochondrial thioredoxin-2 reduces reactive oxygen species, preserves EC function, and reduces atherosclerosis progression in the ApoE −/− model. 33 Conversely, the current study indicates that AIP1 deletion augments hyperlipidemia-induced EC dysfunction (reduction of basal NO activity) at an early phase of atherosclerosis, and AIP1 could limit atherogenic stimuli-induced oxidative stress in vascular endothelium. The mechanism by which AIP1 regulates intracellular reactive oxygen species requires further study.
Taken together, our current study in mouse model of atherosclerosis provides evidence to support the human GWAS that AIP1 is identified as a susceptibility gene for coronary artery diseases. 16 A future analysis of the regulation of AIP1 expression during atherosclerosis should help to determine whether AIP1 is a potential therapeutic target for the prevention of atherosclerosis and other vascular diseases.
